CardieX Limited (CDX.AX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Niall Charles Edgar Cairns ACA, B.Ec, FAICD | Co-Founder & Executive Chairman | 300k | -- | 1964 |
| Mr. Craig R. Cooper BEC, L.L.B. | Co-Founder, Group CEO, MD & Executive Director | 945.67k | -- | 1964 |
| Dr. Ahmad Qasem Ph.D. | Chief Science & Research Officer | 223.97k | -- | 1964 |
| Mr. Douglas T. Kurschinski | Executive VP & Head of Global Sales for AtCor Medical Division | 342.61k | -- | -- |
| Dr. Mark Gorelick Ph.D. | Chief Product Officer | 389.09k | -- | 1975 |
| Ms. Catherine Liao | Chief Strategy Officer | 372.51k | -- | 1980 |
| Dr. Sanjeev Bhavnani | Chief Clinical Officer | -- | -- | -- |
| Ms. Louisa Ho | Company Secretary | -- | -- | -- |
CardieX Limited
- Sector:
- Healthcare
- Industry: Medical Devices
Description
CardieX Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables, home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.
Corporate Governance
Upcoming Events
July 29, 2025 at 7:07 AM UTC - August 4, 2025 at 7:07 AM UTC
CardieX Limited Earnings Date